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Summary
ABCG2 is a multidrug efflux pump associated with
resistance of cancer cells to a plethora of unrelated
drugs. ABCG2 is a ‘‘half-transporter,’’ and previous
studies have indicated that it forms homodimers and
higher oligomeric species. In thismanuscript, electron
microscopic structural analysis directly addressed
this issue. An N-terminal hexahistidine-tagged
ABCG2R482G isoform was expressed to high levels in
insect cells. An extensive detergent screen was em-
ployed to effect extraction of ABCG2R482G from mem-
branes and identified only the fos-choline detergents
as efficient. Soluble protein was purified to >95% ho-
mogeneity by a three-step procedure while retaining
the ability to bind substrates. Cryonegative stain elec-
tron microscopy of purified ABCG2R482G provided 3D
structural data at a resolution ofw18 A˚. Single-particle
analysis revealed that the complex forms a tetrameric
complex (w180 A˚ in diameter 3w140 A˚ high) with an
aqueous central region. We interpret the tetrameric
structureascomprising fourhomodimericABCG2R482G
complexes.
Introduction
Resistance to chemotherapy remains an unconquered
and considerable barrier to the treatment of cancer.
One of the most widespread factors is reduced drug ac-
cumulation by active extrusion mechanisms such as the
ATP Binding Cassette (ABC) transporters. The first dis-
covered was P-glycoprotein (ABCB1), and it has been
implicated most strongly in the resistance of leukemia.
In contrast, ABCC1 (MRP1), and not ABCB1, has been
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in small-cell lung cancer cell lines. Similarly, investiga-
tions with cell lines highly resistant to mitoxantrone or
daunomycin discovered the presence of a third multi-
drug transporter, ABCG2 (BCRP or MXR). These three
ABC proteins play a pivotal role in resistance of cancer
cells to an extraordinary array of anticancer agents and
are known as multidrug transporters due to the promis-
cuity of their substrate interactions.
ABCG2 has been classified to the G subfamily of ABC
transporters, all of which are considered ‘‘half-trans-
porters’’ and comprise one nucleotide-binding domain
(NBD) and a single transmembrane domain (TMD) con-
taining six predicted membrane-spanning segments.
The most distinguishing sequence feature of the ABCG
family is the distinct topology. While the majority of
ABC transporters comprise a TMD followed by a C-
terminal NBD, the ABCG2 protein has an apparent ‘‘re-
versed structure,’’ with the NBD located N-terminal to
the TMD. These structural differences are in stark con-
trast to the more extensively characterized ABCB1 and
ABCC1 multidrug transporters and serve to underlie
the importance of ABCG2 structural studies.
ABCG2 has been directly demonstrated to confer
resistance to mitoxantrone (Nakagawa et al., 1992),
methotrexate (Chen et al., 2003), and camptothecin
derivatives (Robey et al., 2001). Additional studies with
drug-selected cultured cell lines have identified three
different isoforms of ABCG2, with mutations near the
third predicted transmembrane segment localized at
residue 482 (Mitomo et al., 2003; Ozvegy et al., 2002).
The wild-type protein contains an arginine residue,
whereas the two most commonly observed mutations
are either glycine or threonine. The glycine is a gain-of-
function mutation in that resistance to anthracyclines,
such as daunomycin and doxorubicin, is conferred and
the protein is able to transport Rhodamine 123, although
a loss of function with respect to methotrexate is also
observed. The reason for the alteration of function has
yet to be resolved, and translocated compounds, in-
cluding the anthracyclines, Rhodamine 123, and camp-
tothecins, are also substrates of ABCB1. However, not
all ABCB1 substrates, such as vinblastine and calcein-
AM, are recognized by ABCG2. Recent radioligand-
binding data have identified the presence of multiple,
pharmacologically distinct sites on ABCG2 for drug in-
teraction (Clark et al., 2006). However, the precise na-
ture of these sites and their location within the TMDs
has not yet been determined, and there are few selective
inhibitors for the protein.
The minimal functional oligomer of ABCG2 has been
suggested to be a homodimer, a form necessary if it is
to function as an ATP-dependent drug transporter,
and several lines of evidence support this hypothesis.
First, a large body of evidence from ABC transporters
exists and demonstrates that two functional NBDs are
required to support substrate translocation. Structural
analyses with either isolated NBDs or bacterial ABC pro-
teins, including the MsbA homodimer, have revealed
that bound ATP interacts with elements (P loop and
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1624Figure 1. Efficiency of ABCG2R482G Solubilization by a Range of Nonionic and Zwitterionic Detergents
(A–F) Detergent solubilization of ABCG2R482G membranes was performed as described in the Experimental Procedures and was assessed by
immunoblotting of the soluble and insoluble material. Detergents are shown above the sample lanes, and each fraction represented 10% of
the sample. (A), (C), and (E) were obtained with membranes at a concentration of 1 mg$ml21, while (B), (D), and (F) correspond to 10 mg$ml21
total membrane protein.signature sequence) provided by each of the two NBDs
(Reyes and Chang, 2005). Also, it has been established
that two G subfamily members, ABCG5/ABCG8, hetero-
dimerize to enable cholesterol efflux, and that their inter-
action is essential for correct localization of the proteins
to the plasma membrane compartment (Graf et al., 2003).
Studies characterizing ABCG2 function have pointed
to a potential for protein-protein interactions, which
have been suggested to be maintained by disulfide
bond formation (Kage et al., 2002; Litman et al., 2002).
However, other intermolecular interactions, such as
those involving the established GXXXG transmembrane
helix interaction motif (Russ and Engelman, 2000), have
also been implicated (Polgar et al., 2004). Recent evi-
dence gathered from sucrose density gradient sedimen-
tation studies has suggested that while homodimeriza-
tion is abundant, there is no clear dependence on
disulfide bond formation (Xu et al., 2004). Full-length
transporters such as ABCB1 (Poruchynsky and Ling,
1994) and ABCC1 (Rosenberg et al., 2001; Soszynski
et al., 1998) have also been suggested to form oligo-
meric structures, although the functional significance
has not yet been elucidated, unlike that of SUR1-Kir6.2
oligomerization (Mikhailov et al., 2005), which is critical
in mediating potassium conductance.
In the present manuscript, an extraction and purifica-
tion procedure has been developed to enable further
functional and structural analysis of the ABCG2R482G
transporter. The protein proved difficult to extract with
commonly used detergents and ultimately required the
use of fos-choline-16. Drug-binding studies demon-
strate that purified protein is capable of specific interac-
tion with transport substrates. An initial structure for
ABCG2R482G is presented for the purified protein by
using electron microscopy, which indicates that a tetra-
meric complex with an aqueous central region is
formed. We interpret the tetrameric structure as com-
prising four homodimeric ABCG2R482G complexes.Results
Solubilization of ABCG2R482G from
High Five Insect Cells
Recombinant baculovirus containing either the carboxy-
terminal or amino-terminal hexahistidine-tagged con-
structs for ABCG2R482G were transfected into High Five
cells. Immunoblot analysis of expression levels of the
two constructs on crude membranes (not shown) dem-
onstrated a significantly higher level of expression of
the amino-terminal-tagged ABCG2R482G. Binding stud-
ies conducted on crude membranes (Clark et al., 2006)
demonstrated functional interaction with published sub-
strates only in the case of the amino-terminally tagged
construct.
Solubilization Screen for ABCG2R482G
Crude membrane preparations from the infected insect
cells were tested with a range of common nonionic de-
tergents and zwitterionic detergents to investigate the
extraction conditions of ABCG2R482G. The initial screen
(Figures 1A and 1B) showed no extraction with any de-
tergent other than the strong ionic detergent SDS.
Lack of extraction with the glucoside- and maltoside-
based detergents indicated that nonionic detergents
were not cogent extractors. The zwitterionic detergents,
lauryldimethylamine oxide (LDAO), fos-choline (FC), and
cyclofos (CF), as well as the nonionic cymal series (CY),
were screened. Figures 1C and 1D demonstrate weak
extraction of ABCG2R482G by LDAO, FC-12, and CF-5.
In contrast to FC-12, FC-8’s failure to liberate the protein
suggested that the length of the alkyl chain of the
detergent may be important in its ability to extract
ABCG2R482G. Longer chain length variants of the FC de-
tergents were screened in addition to a number of other
conditions (Figures 1E and 1F). Both FC-14 and FC-16
showed extraction irrespective of the protein concentra-
tions used, while pentadecafluoro-octanoic acid (PFO)
only showed relatively weak extraction at 1 mg$ml21.
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further screens.
Optimization of Solubilization of ABCG2R482G
The solubilization efficiency of FC-16 was investigated
by time course solubilization trials. This demonstrated
(Figure 2A) that, at 10 mg$ml21 crude membrane pro-
tein, 1% FC-16, a 60 min solubilization at 4C provided
maximal solubilization. To identify the minimum amount
of detergent required for efficient extraction of
ABCG2R482G, the concentration of the detergent was
varied from 0.002% (43 CMC) to 2% with 10 mg$ml21
crude membranes (Figure 2B). Extraction was only
possible at concentrations of 2% and 1%, indicating
that the protein was highly intransigent to extraction
at low detergent concentrations. As 2% FC-16 gave
slightly more extraction, the concentration of the deter-
gent was fixed and the protein concentration varied
from 10 mg$ml21 to 0.5 mg$ml21 (Figure 2C). This indi-
cated that 2 mg$ml21 crude membranes, 2% FC-16
were the optimal conditions for the solubilization of
ABCG2R482G.
Purification Scheme for FC-16-Soluble ABCG2R482G
Solubilized membranes were analyzed by immobilized
metal affinity chromatography (IMAC) (Figure 3A). How-
ever, the protein interacted weakly with the Ni2+-NTA
resin and was observed to elute at a relatively low (80
mM) imidazole concentration. Immunoblot analysis of
the unbound material (not shown) indicated that the
protein was binding with high efficiency to resin, albeit
weakly. The amino-terminal His tag was not proteolyti-
cally cleaved since the eluted protein retained antihexa-
Figure 2. Optimization of ABCG2R482G Solubilization by FC-16
(A) Membranes containing ABCG2R482G were solubilized with 1%
FC-16 at a protein concentration of 10 mg$ml21 for 1 hr, 2 hr, 4 hr,
and 12 hr at 4C. Insoluble material and soluble proteins were as-
sessed for the presence of ABCG2R482G as described in Figure 1.
(B) Membranes containing ABCG2R482G were solubilized with vary-
ing concentrations of FC-16 (0.002%–2% w/v) at a protein concen-
tration of 10 mg$ml21. Solubilization was undertaken for 60 min at
4C, and efficiency was assessed as described above.
(C) ABCG2R482G solubilization efficiency was assessed by using
varying concentrations (0.5–10 mg$ml21) of membrane protein
with 1% (w/v) FC-16. Solubilization was undertaken for 60 min at
4C, and efficiency was assessed as described above.histidine monoclonal antibody reactivity. The peak
elution fractions (Figure 3A, lanes 5–10) contained impu-
rities and required an additional purification step.
ABCG2R482G-containing fractions were concentrated
and then equilibrated in a 20 mM NaCl buffer. The anion
(MonoQ) exchange served as a pass-through purifica-
tion step, as the majority of ABCG2R482G eluted and
the contaminating protein species bound (Figure 3B).
The unbound ABCG2R482G was concentrated and puri-
fied further by gel permeation chromatography (Figures
3C and 3D). SDS-PAGE analysis of the peak fractions
showed that the sample was purified to homogeneity.
The chromatographic trace shows a single species elut-
ing from the column, indicating that ABCG2R482G had
purified in a single oligomeric state. Comparison to sol-
uble molecular mass standards (Figure 3D, inset) was
performed, and an apparent molecular mass of 430
kDa was determined.
Monomeric ABCG2R482G, as observed on SDS-PAGE,
isw70 kDa. However, the minimal functional quaternary
structure for a half-transporter would be dimerization
with a cognate partner. Removal of reductants from
SDS-PAGE has been a common approach for observing
dimerization. Thus, gel permeation chromatography
was performed in the presence of 5 mM TCEP, a strong
reducing agent, in order to determine if ABCG2R482G
monomers could be observed (data not shown). Addi-
tion of TCEP failed to alter the elution profile of
ABCG2R482G, indicating that its oligomeric state was
highly stable and could not be disrupted at this
stage. Removal of reductants from SDS-PAGE did not
lead to the detection of any dimeric species (data not
shown).
Gel permeation chromatography is a poor technique
for the determination of membrane proteins’ molecular
mass due to their aberrant migration compared to solu-
ble protein standards (Schagger, 2003). Thus, BN-PAGE
was performed as an alternative method by which the
size of the oligomeric ABCG2R482G complex could be
analyzed (Figure 4). This technique gave a single band
that, when compared to soluble protein standards, had
a molecular mass ofw600 kDa.
Drug Binding to Detergent-Solubilized,
Purified ABCG2R482G
The integrity of function of detergent-soluble, purified
ABCG2R482G was assessed by measuring the binding of
known substrates to the protein. ATPase activity was
not measured since the protein was in a detergent-solu-
ble, rather than a reconstituted, state. [125I]Iodoarylazido-
prazosin ([125I]IAAP) was used to photoaffinity label
ABCG2R482G since it has previously been demonstrated
to stimulate ATP hydrolysis by the protein (Ozvegy et al.,
2001). Figure 5A (lane i) demonstrates that [125I]IAAP
was able to specifically photolabel the purified protein.
Moreover, the binding of [125I]IAAP was displaced by
a number of known substrates of ABCG2R482G, including
prazosin, daunomycin, doxorubicin, and Hoechst33342
(Figure 5A). Figures 5B and 5C demonstrate full dose-re-
sponse analysis of the specific [125I]IAAP displacement
by both prazosin and Hoechst33342. These data show
that purified ABCG2R482G retained the ability to interact
with substrates and verified the fidelity of the samples
after chromatography. Purified ABCG2R482G also
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FC-16-solubilized ABCG2R482G was subjected to a three-stage purification scheme. Fractions containing protein are shown with PAGE-Blue-
stained SDS-PAGE.
(A) Fractions obtained from IMAC. Lanes 1–4 show the 60 mM imidazole wash step, and lanes 5–12 show the specific elution of ABCG2R482G at
200 mM imidazole.
(B) Anion exchange chromatography. The majority (>85%) of ABCG2R482G was observed to elute in the unbound fractions (lanes 1–6) at 20 mM
NaCl, while a proportion of ABCG2R482G was observed to elute along with the majority of the impurities when the NaCl concentration was
increased to 500 mM (lanes 10–14).
(C and D) Gel permeation chromatography. (C) Samples corresponding to elution volumes of 8–16 ml are shown, and the (D) corresponding 280
nm UV trace and the ABCG2R482G-containing fractions are indicated. The inset in (D) shows the calibration curve of soluble marker proteins.displayed low-level ATPase activity (data not shown)
that was stimulated 1.5- to 2-fold by prazosin. The levels
of activity were low, presumably because the protein
was not reconstituted into lipid bilayers, a consistent ob-
servation for other ABC transporters (Callaghan et al.,
1997; Modok et al., 2004).
Structural Analyses of the ABCG2R482G Protein
Figure 6A shows a typical area of a micrograph of cryo-
negatively stained FC-16-solublized ABCG2R482G. This
shows that ABCG2R482G forms uniform, large (w170 A˚
in diameter) particles with a size consistent with an olig-
omeric transporter complex. Projections of low-contrast
complexes could be identified from the field of view
(Figure 6A, boxes), with the most identifiable particle
presenting a square/squared ring with a width ofw170
A˚ and a stained central region 60 A˚ in diameter. Other
projections were rectangular in shape (w140 3 170 A˚)
and sometimes had noticeable bilateral symmetry. The
population of complexes was homogeneous and gener-
ally nonaggregated, although some closely packed
particles could be occasionally found and were not
used in the single-particle analysis.EM data collected under cryonegatively stained con-
ditions (n = 7840) were analyzed and, when using refer-
ence-free classification, yielded a variety of projection
classes, as shown in Figure 6B. Several classes had a
noticeable 4-fold rotational symmetry, while other clas-
ses exhibited rounded rectangles with a more prominent
bilateral symmetry, representing projections toward the
top and side views of the complex, respectively. Other
class averages represented various intermediate orien-
tations between the top and side view projections (Fig-
ure 6B). The reference-free classification suggested
that the particles were in a range of orientations under
the preservative conditions, and that they were appro-
priate for 3D structure determination with cross-com-
mon lines projection matching (Ludtke et al., 1999).
Rotational power analysis (Figure 7B, inset) of the un-
symmetrized projection classes showed strong correla-
tion peaks for C2 and C4 rotational symmetries for sev-
eral classes, as well as a weaker C8 peak. C2 symmetry
would suggest a dimeric arrangement of ABCG2R482G
dimers, but the volume of the ABCG2R482G complex
(3,200,000 A˚3) is almost twice that required for four
ABCG2R482G subunits (w400 kDa), which argues against
Cryonegatively Stained EM Structure of ABCG2
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assumption of a protein density of 0.73cm3/g (Collins
et al., 2004). Biochemical considerations and the weaker
C8 versus C4 peak in the power analysis (Figure 6B)
suggested a tetramer of dimers, rather than a ring of
eight monomers, as the likely configuration of the par-
ticles. Moreover, a higher-symmetry (C8) structure
would be readily identifiable in a 3D map in which C4
symmetry had been imposed, hence the application of
C4 symmetry.
Comparison of back projections of the final C4 struc-
ture with the corresponding averages generated from
the unsymmetrized raw data showed excellent correla-
tion (Figure 6C). The final resolution of the 3D structure
was estimated at w18 A˚ by using a FSC = 0.5 criterion
(Figure 6D), and vector matrix analysis (Figure 6B, inset)
revealed that the most populated classes used through
the sampling were clustered around the central regions
of the asymmetric triangle, although no significant gaps
or missing projections were found. Viewed along the C4
rotational axis, the ABCG2R482G oligomer has an obvi-
ous square or four-lobed shape. Viewed from the side,
the ABCG2R482G complex has an appearance similar to
an upturned stool with stumpy legs on one side (Fig-
ure 7A). The structure has a width along the edge of
the square of 150 A˚, a corner-to-corner width of 180 A˚,
and a height of 145 A˚. The structure suggests that the
tetrameric particles are likely to be formed by four trans-
porters, each formed by two ABCG2R482G peptides. To
aid in the interpretation of the structure, we used a ho-
mology model of a full-length ABC transporter of similar
mass to a homodimeric ABCG2R482G (Stenham et al.,
2003) (Figures 7A and 7C). Manual placement of variable
copies of the model within the 3D map (Figure 7C) con-
firmed that four ABCG2R482G homodimers could be fitted
almost exactly within the density map. Comparison of
correlation coefficients also suggested a significantly
better fit with the NBDs located at the bottom of the
structure, as shown in Figure 7C, rather than at the top.
Figure 4. ABCG2R482 BN-PAGE
Purified ABCG2R482G (5 mg) was analyzed by 4%–21% BN-PAGE.
Soluble molecular mass standards are shown for size comparison,
and ABCG2 is indicated by the arrow.An interesting aspect of the interpretation of the struc-
ture as shown in Figure 7C is that it suggests that the
quaternary structure of the complex is stabilized by mo-
lecular contacts between the NBDs via tight packing.
Discussion
Gel permeation chromatography, nondenaturing elec-
trophoresis, and EM structural analyses of the multidrug
transporter ABCG2R482G all reveal a stable quaternary
structure of the protein subunits after detergent solubi-
lization. Based on data from the majority of ABC trans-
porters, it is highly likely that the minimal functional
unit of ABCG2R482G is a dimer; however, the biophysical
analyses presented here indicate that ABCG2R482G
forms an oligomer that is probably arranged as a tetra-
mer of dimers. The cryonegative staining technique
has been used here because the high contrast imparted
by the molybdate ions allows for an efficient classifica-
tion of the single particles, while the microscopy condi-
tions (presence of trehalose, neutral pH, low tempera-
ture) are likely to preserve the native structure of the
protein (De Carlo et al., 2002; El-Bez et al., 2005). Classi-
fication into characteristic projection classes allows for
the subsequent, nonsubjective analysis of symmetry,
which has strongly indicated a C4 rotational symmetry.
This concurs with the apparent molecular mass ob-
tained by BN-PAGE. Finally, it was possible to dock
four copies of a homology model for an ABC transporter
almost exactly into the density available in the 3D map.
In summary, these various data point to the presence
of a tetrameric arrangement, which is likely to be com-
posed of (four) homodimeric ABCG2R482G units.
ABCG2R482G expressed in insect cells was difficult to
solubilize by conventional mild nonionic and zwitterionic
detergents. The most effective detergents to achieve
solubilization of ABCG2R482G were the long-chain Fo-
scholine derivatives. This finding was in contrast to sim-
ilar investigations with ABCB1, which was readily solubi-
lized from membranes by mild detergents (Taylor et al.,
2001). However, they reported that a considerable pro-
portion (w40%–50%) of the ABCB1 was not extractable.
It has become increasingly evident that many ABC
transporters are resistant to extraction from insect cell
membranes. ABCA4 (unpublished data) is not extracted
by detergents such as b-OG and DDM, yet the lysophos-
pholipid analogs FC-14 and -16 are efficient extractors.
In addition, Ramjeesingh et al. (1997) reported that
CFTR extraction from insect cells required PFO for sol-
ubilization, and that this necessitated a long incubation
time. An additional technical difficulty encountered with
ABCG2R482G was the relatively low binding affinity to the
IMAC resin compared to that reported for ABCB1 (Taylor
et al., 2001), SUR1 (Mikhailov et al., 2005), and ABCC1
(Chang et al., 1997). This observation suggests that the
His tag of ABCG2R482G is at least partially occluded by
the structure, which may be related to the quaternary
structure reported here.
Functional data based on the catalytic cycle of ABC
transporters strongly suggest that two NBDs are re-
quired to power drug translocation; i.e., the minimal
functional unit for ABCG2 should be a homodimer. Pre-
vious studies of ABCG2 have indicated a range of non-
specified and undetermined oligomeric states after
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(A–C) Purified ABCG2R482G (1 mg) was incubated with [125I]IAAP as described in the Experimental Procedures. Samples were resolved by 8%
SDS-PAGE, and fixed gels were imaged by autoradiography. (A) Substrate additions were: lane i, no addition (i.e., IAAP alone); ii, DMSO (solvent
control); iii, prazosin (300 mM); iv, doxorubicin (100 mM); v, daunomycin (100 mM); vi, Hoescht33342 (3 mM). (B and C) ABCG2R482G was incubated in
the presence of varying concentrations (1 nM–300 mM) of (B) prazosin or (C) Hoechst33342. The autoradiograms (upper panels) demonstrate the
ABCG2R482G crosslinked with [125I]IAAP, and the amount of labeling was quantified by densitometry (lower panels) and was analyzed with non-
linear regression.extraction with TX-100 and analysis by gel filtration and
density gradient centrifugation (Bhatia et al., 2005; Xu
et al., 2004). Gel permeation chromatography of
ABCG2R482G indicated a single oligomeric species and
a consistent molecular mass of 430 kDa. Allowing for
a detergent contribution, this could be interpreted as ev-
idence for a dimer of dimers. However, these data are
probably misleading, as gel permeation chromatogra-
phy can be a poor analytical tool for membrane protein
mass determination (Ford et al., 1990); its benefit in the
present study was to demonstrate the homogeneity of
protein preparations. Based on the molecular mass of
monomeric ABCG2R482G, a tetramer of dimers structure
would be predicted to have a molecular mass of w560
kDa protein plus a detergent shell of unknown mass,
possibly 50–100 kDa. This would be consistent with
the w600 kDa molecular mass observed by BN-PAGE.
Some density in the 3D map around the TMDs may arise
due to a band of detergent around the exposed hydro-
phobic residues, although the detergent shell will vary
from one particle to another, and hence may be at least
partially averaged out by the analysis.
It is difficult to discriminate whether the observed
tetramer of dimers is the native in vivo state for
ABCG2R482G in biological membranes or a by-product
of the purification procedure. The oligomeric state offunctionally active, purified membrane proteins can de-
pend on the detergent used in the purification (Ford
et al., 1990). Similarly, overexpression of the recombi-
nant protein can also facilitate quaternary interactions.
Observation of ABCG2R482G interaction with the sub-
strates prazosin and Hoechst33342 indicates that the
purified protein has retained function. Moreover, there
are numerous reports of ABC transporters associating
in various oligomeric states. For example, Pdr5p, the
major multidrug exporter in Saccharomyces cerevisiae,
was observed by EM as a dimer of dimers. Atomic force
microscopy of another ABC protein, CFTR, expressed in
native ‘‘inside-out’’-oriented membrane patches (Schil-
lers et al., 2004), reports a similar dimeric arrangement,
as did previous freeze-fracture EM studies (Eskandari
et al., 1998). However, detergent-solubilized CFTR
(Awayn et al., 2005) may also adopt a dimeric organiza-
tion, depending on the purification detergent. YvcC,
which, like ABCG2R482G, is a ‘‘half-transporter,’’ forms
an unusual ring of ABC transporters after detergent
removal, and each individual transporter subunit is ori-
ented perpendicular to the rotational axis of the ring
(Chami et al., 2002). Recently, a tetrameric organization
of the SUR1-Kir6.2 protein has been observed by EM
(Mikhailov et al., 2005), and an arrangement of the
NBDs of SUR1 that is almost identical to those predicted
Cryonegatively Stained EM Structure of ABCG2
1629Figure 6. Cryonegatively Stained Electron Microscopy and Single-Particle Analysis of ABCG2R482G
(A) Low-contrast individual cryonegatively stained oligomeric complexes are shown in boxes. The image was recorded atw3.0 mm underfocus
and has been CTF corrected and low-pass filtered to 20 A˚. The inset shows the FFT of the EM data with concentric Thon rings extending to the
edge of the FFT and a theoretical resolution of 6.2 A˚. The scale bar is 500 A˚.
(B) Montage of some of the unsymmetrized ABCG2R482G class averages produced by reference-free classification and averaging of particles
imaged by cryonegatively stained EM. Data were CTF corrected and low-pass filtered (25 A˚) prior to classification. Each individual box is
237 3 237 A˚, and the circular mask applied has a diameter of 211 A˚.
(C) Correlation of experimental projection averages to the final 3D structure. The lower row shows a selection of the experimental analyses (no
symmetry imposed) with corresponding back projections from the final C4-symmetrized 3D structure (upper panels). Boxes are 237 3 237 A˚.
(D) FSC plot calculated by comparison of two separate 3D structures calculated by splitting the data set into two. The two structures were thresh-
olded at 1.05s above the mean density, and C4 symmetry was applied (Ludtke et al., 1999). The inset shows the distribution of class averages
used to calculate the 3D structure between Euler angles c, 4, and f.for ABCG2R482G herein is seen. The tetrameric associa-
tion of SUR1 proteins with a tetramer of KATP channels
is in agreement with functional information on the oligo-
meric state (Clement et al., 1997).
Recent pharmacological data with ABCG2R482G sup-
port a potential functional role for the oligomeric asso-
ciation of protein subunits. Radioligand-binding data in-
dicate that drug interaction with ABCG2R482G in native
membranes is characterized by the presence of multiple
and pharmacologically distinct binding sites. Moreover,
drug-binding sites display a complex allosteric commu-
nication. One possible explanation is allosteric interac-
tion between multiple sites within the functional
ABCG2R482G dimer; however, these effects may also
be achieved by interaction between multiple dimers of
the protein within a higher oligomer.
To our knowledge, the data presented here provide
the first 3D information on the oligomeric structure of
ABCG2R482G, which belongs to the subsection of ABC
transporters with a ‘‘reverse topology.’’ A robust andefficacious purification procedure has been established
that will enable further biochemical characterization of
the pharmacophoric properties via reconstitution of
the protein. The stable oligomeric association provides
us with a means to pursue further structural studies
with cryonegative-stained electron microscopy of sam-
ples in thin vitreous ice.
Experimental Procedures
Materials
Octyl-b-glucoside (b-OG) and Zwittergent (ZW) 3-16 were pur-
chased from Merck Biosciences (Nottingham, UK), CHAPS was pur-
chased from Sigma (Poole, UK), and pentadecafluoro-octanoic acid
(PFO) was purchased from Fluorochem (Old Glossop, UK). Foscho-
line (FC-) (8, 12, 14, and 16), cyclofos (CF-) (2 and 5), cymal (CY-)
(2 and 4), dodecyl-b-maltoside, dodecyl-b-maltoside (DDM), and
lauryldimethylamine oxide (LDAO) were obtained from Anatrace
(Maumee, Ohio). The FPLC columns Histrap, MonoQ 5/50, and
Superdex S200 were purchased from GE Healthcare (Chalfont St.
Giles, UK).
Structure
1630Figure 7. 3D Structure and Interpretation
(A) Sections through the height of the ABCG2R482G complex (i.e., slices perpendicular to the C4 axis and displaying bilateral symmetry) are shown
on the left, with corresponding positions of the slice planes indicated in the side view slab in the center. An indication of the position of the mem-
brane with respect to the side view is indicated on the right, as predicted from the positioning of the homology model (far right). Slabbed sections
have the following display thresholds: green, 1.05s; red, 2s; orange, 2.5s; yellow, 3s; cyan, 3.5s; and blue, 4s. The volume was low-pass filtered
to 18 A˚ resolution, and a high-pass Fermi filter was applied to boost higher-resolution frequency information. The scale bar is 100 A˚.
(B) Rotational power analysis of a typical class average displaying some rotational symmetry (Collins et al., 2003). The class average (represent-
ing 110 particles) was low-pass filtered to 25 A˚ resolution.
(C) Surface structure and interpretation. Surface of the ABCG2R482G complex (left column), as viewed from the side (upper row), the top (lower
row), and an intermediate view (center row). Corresponding views displaying the fitting with four copies of the homology model are shown in the
right-hand column.Generation of Recombinant Baculovirus Encoding
N-His6-ABCG2
R482G
An ABCG2 cDNA-containing plasmid, encoding glycine at position
482 (ABCG2R482G), was obtained from Dr. T. Litman (University of
Copenhagen). Oligonucleotide primers (50-CTAGACTCGAGCGGCG
CCATGTCTTCCAGTAATG-30 and 30-CTTGGTACCGAGCGCGGCC
GCCTAAGAATATTTTTTAAG-50) were employed to amplify the
cDNA and add 50 KasI and 30 NotI restriction sites (underlined).
The resultant PCR product was digested and subcloned into the
pFastBac-HTC vector (Invitrogen), generating a cDNA that encodes
an N-terminal extension to ABCG2R482G of MSYYHHHHHH DYDIPTT
ENLYFQGAMSSSN, where the affinity tag is italicized, the TEV-
protease cleavage site is in bold, and the first five amino acids of
the open reading frame of ABCG2R482G are underlined. The fidelity
of PCR was confirmed by DNA sequencing of this resultant con-
struct. This vector was transformed into chemically competent
DH10Bac E. coli cells. Putative recombinant bacterial colonies
were restreaked to ensure no contamination by nonrecombinant
bacteria and were further screened by PCR, after isolation of high-
molecular weight bacmid DNA. Insect cells (Sf9, 9 3 105 cells per
30 mm dish) were transfected with recombinant bacmid DNA (3 mg
DNA, 6 mg lipofectin) to produce an initial viral titer suitable for further
amplification as previously described (Taylor et al., 2001).
Expression of ABCG2R482G and Isolation of
Insect Cell Membranes
The Trichoplusia ni (High Five) cell line was routinely used for the ex-
pression of ABCG2R482G and was maintained in shaking suspension
cultures as previously described (Rothnie et al., 2004). Crude mem-
brane preparations were isolated as previously described (Tayloret al., 2001), with the exception that buffers contained 20 mM
MOPS (pH 7.4), 200 mM NaCl, and 0.25 M sucrose.
ABCG2R482G Solubilization Trials
Membranes were solubilized in 20 mM MOPS (pH 7.4), 200 mM NaCl,
1.5 mM MgCl2, 20% glycerol buffer containing, minimally, 23 CMC
of the detergents. Protease inhibitors were maintained throughout
the solubilization and purification. Solubilizations were incubated
for 60 min at 4C (except for PFO, which was incubated at 20C)
and were mixed, and the soluble fractions were then isolated by ul-
tracentrifugation (100,0003 g, 60 min). Insoluble material was resus-
pended in 10% SDS, and equivalent protein concentrations were
analyzed by 10% SDS-PAGE and immunoblotting. Immunoblotting
analysis was performed by using an anti-6xHis HRP-conjugated
monoclonal antibody from R & D (Abingdon, UK) and was visualized
by ECL.
Chromatographic Isolation of ABCG2R482G
Solubilized protein was analyzed by immobilized metal affinity chro-
matography (IMAC) by using a HisTrap column with a stepwise gra-
dient from 40 mM to 800 mM imidazole. Partially purified protein was
concentrated by using centrifugal concentrators with a molecular
weight (MW) cutoff of 100 kDa (Millipore, UK). The concentrated
sample was diluted 15-fold in 20 mM MOPS (pH 7.4), 20 mM NaCl,
1.5 mM MgCl2, 20% glycerol, 0.1% Fos-choline-16 (FC-16) and
was loaded onto a MonoQ 5/50 column with a step gradient from
20 mM NaCl to 500 mM NaCl. Gel permeation chromatography
was performed in 20 mM MOPS (pH 7.4), 50 mM NaCl, 1.5 mM
MgCl2, 20% glycerol, 0.1% FC-16 on a Superdex S200 10/30 column
at a flow rate of 0.3 ml.min21. Soluble molecular mass standards
Cryonegatively Stained EM Structure of ABCG2
1631used were from the High Molecular Mass Calibration kit from Sigma
(Poole, UK). Retention time of the molecular mass standards was an-
alyzed as described (Andrews, 1964; Whitaker, 1963). BN-PAGE
analysis was performed as described by Schagger et al. (1994). Pro-
tein determination was performed by using the BioRad Dc Brad kit.
BN- and SDS-PAGE gels were stained with PAGE-Blue from Helena
Biosciences (Gateshead).
Drug Binding by ABCG2R482G
ABCG2R482G (1 mg) was incubated with [125I]iodoarylazidoprazosin
([125I]IAAP) (6 nM) in the absence or presence of varying concentra-
tions of known substrates for 2 hr at 20C in the dark. Samples (30 ml)
were then incubated for 10 min on ice and irradiated at 260 nm
(100W) for 8 min on ice. After irradiation, 10 ml of 43 Laemmli buffer
was added to the samples, which were then analyzed by 8% SDS-
PAGE. The gels were washed in water and fixed in 25% (v/v) isopro-
panol and 10% (v/v) acetic acid. Fixed gels were dried and exposed
to photographic film. Where competing drugs were used, the com-
pounds were added from concentrated stocks in DMSO, and the
solvent concentration was maintained at below 1% (v/v). Drugs
were added at concentrations between 30 nM and 1 mM.
Cryonegative and Negative Staining of ABCG2R482G
Carbon-coated copper grids (400 mesh) were glow discharged for
30 s and placed on the surface of a 10 ml droplet of sample containing
100 mg.ml21 ABCG2R482G for 2 min. Cryonegative staining was per-
formed as described by Adrian et al. (1998).
Image Processing and Structure Calculation
from ABCG2R482G EM Data
Data were processed in a subsequent manner (Table 1). Detergent-
solubilized complexes were interactively selected by using BOXER
and were contrast normalized. The contrast transfer function (CTF)
for each micrograph was determined by using CTFIT (Ludtke
et al., 1999), and phase corrections were applied. A set of refer-
ence-free class averages was then generated. Following estab-
lished strategies, a preliminary 3D model was determined from class
averages that represented distinct views of the ABCG2R482G com-
plex. Relative orientations of the characteristic views were deter-
mined by using a Fourier common-lines routine, and resulting aver-
ages were combined to generate the preliminary 3D model. The
structure was refined by using C4 symmetry, using eight rounds of
iterative projection matching, with each refinement assessed by ex-
amining convergence by comparison of the Fourier Shell Correlation
(FSC) of the 3D models generated from each iteration. The final 3D
volume was fully converged after six rounds of iterative refinement,
and resolution was determined by FSC analysis. A homology model
Table 1. Cryo-Electron Microscopy and Image Analysis
Information Used for the Single-Particle 3D Reconstructions
Cryonegatively
Stained Data
Negatively
Stained Data
Microscope Philips CM200 FEG Tecnai CM10
Mode TEM low dose
at <100K
TEM low dose
Operating voltage 200 kV 100 kV
Micrograph film — Kodak SO-163
Digitization Gatan 4Kx4K
CCD camera
UMAX 3000
Spot size 5 3
Dose (electron/A˚2) <20 <40
Calibrated magnification 38,000 43,000
A˚/pixel at specimen level 3.1 3.7
Defocus range (A˚) 212,000 to 235,000 22,000 to 25,000
Selection box (A˚) 237 300
Total particles 7,840 2,240
Particle classes 131 60
Reconstruction
mask radius (A˚)
220 200
Spatial resolution,
FSC = 0.5 (A˚)
18 22of ABCG2 (J.D. Campbell, personal communication) based on an
atomic-scale structural model of ABCB1 (Stenham et al., 2003)
was docked in the 3D map by using Chimera. After fitting four copies
of the model, a 3D map at the same resolution as the experimental
structure was generated from the model tetramer. This map was
then aligned rotationally and translationally against the experimental
structure, and an FSC was calculated between the two aligned
maps. A similar procedure was carried out with the whole model
rotated through 180 so that the NBDs were facing in the opposite
direction.
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